Award
Delivery Order #SPE2DR26FN4Y2
Delivery Order for HAVRIX Vaccine under AmerisourceBergen Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$1,478.80
Ceiling
$1,478.80
Awarded
March 02, 2026
Period of Performance
Mar 02, 2026 – Mar 03, 2026
Identifier
SPE2DR26FN4Y2
NAICS
424210
This award represents a delivery order contract under a previously established Indefinite Delivery Vehicle (IDV) awarded to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company. The contract procures a specific pharmaceutical product, namely the HAVRIX vaccine in a precise dosage format, signifying its role in supporting immunization efforts. This contract ensures timely and efficient delivery of critical vaccine units to the specified location, contributing to public health safeguard initiatives. The scope of work includes the delivery of 1,440 units of the HAVRIX vaccine in syringe milliliter format, supporting ongoing healthcare operations. This order is part of a continuing supply relationship and is crucial for maintaining vaccine availability within government health programs. The award stems from a non-competitive continuation under the existing vehicle, emphasizing expedited procurement to meet immediate needs. The contract has a short, definite performance window, underscoring prompt delivery requirements.
Description
4571005460!HAVRIX 1,440 UNIT/ML SYRINGEML